Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.03 Million GBP | 1.06% |
| 2022 | 4.98 Million GBP | 113.44% |
| 2021 | 2.33 Million GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 2.24 Million GBP | 215646.52% |
| 2023 FY | 5.01 Million GBP | 0.6% |
| 2023 Q4 | 1478.00 GBP | 0.0% |
| 2023 Q3 | 1478.00 GBP | -99.93% |
| 2023 Q1 | 1041.50 GBP | -99.97% |
| 2022 Q2 | 1.87 Million GBP | 213598.63% |
| 2022 FY | 4.98 Million GBP | 113.44% |
| 2022 Q4 | 3.36 Million GBP | 208063.27% |
| 2022 Q3 | 1617.00 GBP | -99.91% |
| 2022 Q1 | 876.00 GBP | 0.0% |
| 2021 FY | 2.33 Million GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 3.65 Million USD | -38.028% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -275.612% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -91.778% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 82.949% |
| GB Sciences, Inc. | 1.42 Million USD | -254.732% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -47.989% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2189.643% |
| Skye Bioscience, Inc. | 13.54 Million USD | 62.805% |
| Zenith Capital Corp. | 8.94 Million USD | 43.654% |
| Agentix Corp. | 1.37 Million USD | -267.339% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 0.06% |
| Biomind Labs Inc. | 994.18 Thousand USD | -406.849% |
| ContraFect Corporation | 56.88 Million USD | 91.142% |
| CSL Limited | 3.44 Billion USD | 99.854% |
| CytoDyn Inc. | 18.05 Million USD | 72.095% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -170.279% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1193.491% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 91.227% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1112.817% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -235.509% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -445.636% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 86.475% |
| SQZ Biotechnologies Company | 85.61 Million USD | 94.115% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -145.96% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 94.194% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -72.791% |
| Mesoblast Limited | 5.9 Million USD | 14.622% |
| Marizyme, Inc. | 19.23 Million USD | 73.81% |
| Genus plc | 147.7 Million USD | 96.588% |
| Pharming Group N.V. | 225.49 Million USD | 97.765% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 39.573% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -240.76% |
| IMV Inc. | 37.7 Million USD | 86.637% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -80.586% |
| MultiCell Technologies, Inc. | 567.42 USD | -887954.704% |
| ONE Bio Corp. | 6.44 Million USD | 21.802% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 94.137% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 79.612% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -186.359% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 24.993% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 20256.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 68.526% |
| Alpha Cognition Inc. | 9.7 Million USD | 48.082% |
| Enzolytics Inc. | 2.17 Million USD | -131.199% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.671% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -382.663% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -109.528% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.389% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -2.462% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -1825.296% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -105.228% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -2838.038% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -162.324% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 42.603% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -14.297% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 3.74 Million USD | -34.502% |
| Helix BioMedix, Inc. | 1.97 Million USD | -155.523% |
| EV Biologics, Inc. | 531.96 Thousand USD | -847.248% |
| Q BioMed Inc. | 3.43 Million USD | -46.626% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 53.63% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 94.927% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | 78.067% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -174.591% |
| HST Global, Inc. | 140.9 Thousand USD | -3476.118% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -277.331% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -347.947% |
| Halberd Corporation | 74.84 Thousand USD | -6632.851% |
| Resverlogix Corp. | 12.71 Million USD | 60.36% |
| Cell Source, Inc. | 4.32 Million USD | -16.499% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -219.054% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.31 Million USD | 31.07% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -28824.861% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.46 Million USD | -104.276% |
| Kadimastem Ltd | 2.41 Million USD | -109.077% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -18.889% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -2676.538% |
| LadRx Corporation | 3.81 Million USD | -32.195% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -445.636% |
| Affymax, Inc. | 39.38 Million USD | 87.206% |
| Itoco Inc. | 919.14 Thousand USD | -448.228% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -350.313% |
| Mobile Lads Corp. | 554.54 Thousand USD | -808.671% |
| International Stem Cell Corporation | 5.27 Million USD | 4.401% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 3.82 Million USD | -31.906% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -19920.66% |
| Qrons Inc. | 643.67 Thousand USD | -682.846% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -254.911% |
| SYBLEU INC | 160.87 Thousand USD | -3032.226% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -125.976% |
| Rebus Holdings, Inc. | 664 Thousand USD | -658.886% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -177.429% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -9472.205% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -24670.191% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 86.105% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -211.434% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -584.8% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -61.974% |
| Neutra Corp. | 243.82 Thousand USD | -1966.68% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 71.135% |
| PureTech Health plc | 144.59 Million USD | 96.515% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 75.407% |
| IXICO plc | 4.7 Million USD | -7.053% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 42.719% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 95.721% |
| CSL Limited | 3.89 Billion USD | 99.871% |
| Cellectis S.A. | 97.32 Million USD | 94.822% |